HeartFlow Stock After Institutional Moves: Buy or Not?
When an institutional investor takes a large position in a biotech stock, it can signal potential credibility or risk...
Choosing a wide market index fund for retirement involves evaluating diversification, costs, and alignment with your time horizon.
28,206 articlesWhen an institutional investor takes a large position in a biotech stock, it can signal potential credibility or risk...
SpaceX’s impending IPO is driving the launch of leveraged ETFs designed to amplify bets on the rocket company, offeri...
A surprise leadership change jolted Copart’s stock, sparking an intraday drop. This article breaks down the why, what...
In the first half of 2026, here's plug power stock surged 37.6%, signaling a renewed optimism around hydrogen fuels a...
As biotech investors digest Recursion's latest quarterly results, this Deep Dive breaks down what recursion (rxrx) 20...
A senior U.S. senator warns that college grad unemployment will surge as AI reshapes entry-level work, potentially up...
As Zebra Technologies previews its Q1 2026 results, investors weigh hardware demand, software subscriptions, and marg...
Ben Chester navigated a path from crushing debt renting to a thriving landlord with eight properties, three short-ter...
Investors are urged to rethink risk in today’s markets: volatility is temporary, but liquidity squeezes and balance-s...
NuScale Power has seen wild swings, but the story isn’t just nostalgia for a boom. This piece breaks down the odds of...
The surge in late applied digital (apld) stock has many investors asking if the window to buy has closed. This guide ...
The (onon) 2026 earnings call offers critical clues about growth drivers, margin reset, and next steps for investors....